JT
AMRX icon

Jupiter Topco’s Amneal Pharmaceuticals AMRX Stock Holding History

Jupiter Topco’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32M Buy
+76,216
New +$1.04M ﹤0.01% 1673

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Jupiter Topco's AMRX Position: Q2 2026 in Review

Jupiter Topco opened a new position in Amneal Pharmaceuticals (AMRX) in Q2 2026: 76,216 shares worth $1.32M. The stake represents ﹤0.01% of the portfolio and ranks #1673 among its holdings.

288 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Jupiter Topco held 76,216 shares of Amneal Pharmaceuticals worth $1.32M as of Q2 2026.
  • Amneal Pharmaceuticals was a new Jupiter Topco position in Q2 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #1673 holding.
  • 288 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.